Lv2
130 积分 2021-09-10 加入
Tirzepatide did not impact metabolic adaptation in people with obesity, but increased fat oxidation
1天前
已完结
Tirzepatide is an imbalanced and biased dual GIP and GLP-1 receptor agonist
7天前
已完结
Tirzepatide for maintenance of bodyweight reduction in people with obesity in the USA (SURMOUNT-MAINTAIN): a multicentre, double-blind, randomised, placebo-controlled trial
15天前
已完结
Comparative Pharmacology of the 3 Marketed Dual Orexin Antagonists—Daridorexant, Lemborexant, and Suvorexant: Part 1: Pharmacokinetic Profiles
3个月前
已完结
Comparative Pharmacology of the 3 Marketed Dual Orexin Antagonists—Daridorexant, Lemborexant, and Suvorexant—Part 2. Principal Drug Metabolizing Enzyme, Drug-Drug Interactions, and Effects of Liver and Renal Impairment on Metabolism
3个月前
已完结
Abstract 17217: ActRIIA-Fc Rebalances Activin/GDF and BMP9 Signaling to Attenuate Experimental Pulmonary Hypertension
3个月前
已关闭
Dexrazoxane Alleviated Doxorubicin-Induced Nephropathy in Rats
6个月前
已完结
Differential disruption on glucose and insulin metabolism in two rat models of diet-induced obesity, based on carbohydrates or lipids
7个月前
已完结
Synaptotagmin-3 interactions with GluA2 mediate brain damage and impair functional recovery in stroke
9个月前
已完结
皖公网安备34019202002308
